New hope for women with Tough-to-Treat cervical cancer
NCT ID NCT07230626
Summary
This study is testing whether a new drug called SYS6002 works better than standard chemotherapy for women whose cervical cancer has returned or spread after previous treatments. It will involve about 412 women aged 18-75 whose cancer progressed despite platinum-based chemo and immunotherapy. The main goal is to see if SYS6002 helps patients live longer compared to current chemotherapy options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.